Related Experiment Video

Updated: Apr 26, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

12.8K

Kasabach-Merritt phenomenon in hepatic angiosarcoma

Stefan Habringer1, Ann Boekstegers, Lukas Weiss

  • 1IIIrd Medical Department, Paracelsus Medical University, Salzburg, Austria.

British Journal of Haematology
|July 26, 2014
PubMed
Summary

No abstract available in PubMed .

Keywords:
coagulopathysarcomathrombocytopenia

More Related Videos

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.0K

Related Experiment Videos

Last Updated: Apr 26, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

12.8K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.0K

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

30
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
30

Articles linked to this work by shared authors, journal, and citation graph.

Therapeutic management of resectable mismatch-repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: a real-world analysis from Austria.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026

Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real-World Case Series.

EJHaem·2026

CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.

AIDS (London, England)·2026

Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma Registry.

Journal of orthopaedic surgery and research·2026

Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold?

Cancers·2026

AGMT mCRC Registry Third-Line and Beyond: a multicentric real-world platform with integrated imaging and biosample database for later-line metastatic colorectal cancer.

Future oncology (London, England)·2026

Design of a modified platelet immunofluorescence test to assess platelet-reactive antibody burden and its association with platelet functional exhaustion and clinical features in chronic immune thrombocytopenia.

British journal of haematology·2026

Comorbid conditions after allogeneic haematopoietic stem cell transplantation in young adults in Germany-A prospective, multicentre trial.

British journal of haematology·2026

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

British journal of haematology·2026

Long-term follow-up of PET/CT-adapted therapy after three cycles of ABVD for all stages of classic Hodgkin lymphoma: Results of the GATLA LH-05 trial.

British journal of haematology·2026

Second primary cancers in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia-cumulative burden without generalized excess cancer risk.

British journal of haematology·2026

Prognostic impact of blood Epstein-Barr virus-DNA in patients with peripheral T-cell lymphoma, not otherwise specified.

British journal of haematology·2026

The MEG3-miRNA regulatory axis could potentially modulate response to biological therapies in psoriatic arthritis.

Pharmacological reports : PR·2026

Validation of low-volume plasma dilution protocols for human cytomegalovirus DNA quantification using the cobas CMV assay.

Microbiology spectrum·2026

Discovery of four novel phenuiviruses from public mosquito RNA-seq data using reference-guided assembly.

Microbiology resource announcements·2026

Hemifacial Microsomia with Extensive Ipsilateral White Matter Hyperintensity: A Case Report.

Case reports in neurology·2026

CD4 Count and Clinical Outcomes of Mpox in People Living With HIV: A Systematic Review and Meta-Analysis.

Health science reports·2026

Validation of digital PCR as a complementary tool to MS2 plaque assay for virucidal activity assessment.

Frontiers in public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us